Relation between Bcl-2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer
- 1 March 1998
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 34 (4) , 251-258
- https://doi.org/10.1002/(sici)1097-0045(19980301)34:4<251::aid-pros2>3.0.co;2-k
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Apoptotic versus proliferative activities in human benign prostatic hyperplasiaHuman Pathology, 1996
- EARLY EXPRESSION OF bcl-2 PROTEIN IN THE ADENOMA-CARCINOMA SEQUENCE OF COLORECTAL NEOPLASIAThe Journal of Pathology, 1996
- Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell modelThe Prostate, 1996
- bcl-2: Role in epithelial differentiation and oncogenesisHuman Pathology, 1996
- Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: Simultaneous demonstration of cell-specific epithelial markersHuman Pathology, 1994
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.Proceedings of the National Academy of Sciences, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.Proceedings of the National Academy of Sciences, 1986
- Morphologic and endocrine aspects of prostatic functionThe Prostate, 1983